AGY — Allergy Therapeutics Share News
0.000.00%
- £669.42m
- £716.72m
- £55.04m
REG - Allergy Therapeutics - Phase I VLP Peanut PROTECT trial progress
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Cavendish Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Allergy Therapeutics - Satisfaction of FDI clearance conditions
AnnouncementREG - Cavendish Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Panmure Gordon (UK). Allergy Therapeutics - Form 8.5 (EPT/RI)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Cenkos Securities Allergy Therapeutics - Form 8.5 (EPT/NON-RI)
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement